Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection. Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free s...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Transl Med
Main Authors: Boussios, Stergios, Moschetta, Michele, Karihtala, Peeter, Samartzis, Eleftherios P., Sheriff, Matin, Pappas-Gogos, George, Ozturk, Mehmet Akif, Uccello, Mario, Karathanasi, Afroditi, Tringos, Michail, Rassy, Elie, Pavlidis, Nicholas
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2020
Fag:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812175/
https://ncbi.nlm.nih.gov/pubmed/33490218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.156
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker